Home/Filings/4/0001640455-22-000016
4//SEC Filing

Trehu Elizabeth 4

Accession 0001640455-22-000016

CIK 0001640455other

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 7:36 PM ET

Size

6.6 KB

Accession

0001640455-22-000016

Insider Transaction Report

Form 4
Period: 2022-02-01
Trehu Elizabeth
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2022-02-01+27,500112,702 total
  • Award

    Stock Option (Right to Buy)

    2022-02-01+55,00055,000 total
    Exercise: $7.56Exp: 2032-02-01Common Stock (55,000 underlying)
Footnotes (1)
  • [F1]The option will vest quarterly in 16 equal installments following January 1, 2022.

Issuer

Jounce Therapeutics, Inc.

CIK 0001640455

Entity typeother

Related Parties

1
  • filerCIK 0001693456

Filing Metadata

Form type
4
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 7:36 PM ET
Size
6.6 KB